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The ruptured anterior cruciate ligament (ACL) has poor healing 
capabilities itself and so far no surgical procedures can fully and reliably restore 
its function. Tissue engineering has provided possibilities to fabricate ideal ACL 
substitutes with combined techniques and one of the potential biomaterials is silk. 
Silk fibers from silkworm have good record in clinical applications and superior 
mechanical properties which make them potent biomaterials for ACL repair and 
regeneration. 
In this study, a novel biocompatible 3-D scaffold was knitted out of raw 
silk fibers, processed to remove sericin, a glue-like protein on the surface of silk 
fibers which may cause foreign body response, and coated with silk sponge to 
provide a large biomimetic surface area for cells to attach. Bone marrow stem 
cells (BMSC) were seeded on the scaffold and cell proliferation, viability, 
morphology and differentiation were investigated. Compared with a conventional 
cell immobilizing method – fibrin glue, this 3-D scaffold showed better capability 
of supporting the adhesion, proliferation and differentiation of BMSCs. BMSCs 
readily attached to the scaffold and formed cell sheet on the scaffold 1 week later. 
Both the cell viability and cell morphology on the 3-D scaffold were better than 
those in fibrin glue during 2 weeks. Moreover, the scaffold potentially induced 
BMSCs’ differentiation into ACL fibroblasts. In vivo study used New Zealand 
White rabbits which were implanted with the scaffold either seeded with BMSCs 
or not. Four weeks post operation, fibroblasts in-growth and synthesis of collagen 
type I, collagen type III and tenascin-C were seen in the constructs initially seeded 
with cells. Further analysis will be carried out on samples with longer 
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1.1 ACL injuries and currently available repair strategies 
The anterior cruciate ligament (ACL) is one of the main stabilizers of knee 
joint, which limits anterior translation of the tibia [1]. As sports are getting 
popularized, the occurrences of ACL related injuries are also on the rise. ACL 
rupture may lead to pain and discomfort, severely limited mobility, and even 
degenerative joint diseases [1-5]. Since the intrinsic self-healing potential of ACL 
is poor and access to blood supply is limited after rupture, it is difficult for injuries 
of the ACL to heal by itself and surgical treatments are usually required [6]. 
Biological substitutes have been the most popular treatment for repair or 
replacement of injured ACL clinically. Three options are available, namely: 
autografts, allografts and xenografts [7]. Each has its own limitations and cannot 
be regarded as an ideal choice. Among them, autografts have produced the most 
satisfactory long-term results and are therefore referred to as the “gold standard” 
[8]. Autografts are usually taken from the patient’s own patellar tendon, hamstring 
tendon, or quadriceps tendon at the time of surgery. For patella tendon graft, a 
piece of bone from the patella and from the insertion point at the tibia is usually 
removed along with the tendon. The “bone-patellar-bone” graft is then fed through 
a tunnel drilled through the tibia, drawn across the knee, and anchored into a 
tunnel drilled through the femur [9]. Autografts usually have good initial 
mechanical strength and are capable of promoting cell proliferation and new tissue 
growth [9, 10]. However, the harvest of these tissues needs additional surgery on 
the patient, and removal of these tissues may cause donor site morbidity, which 
often involves pain, muscle atrophy and tendonitis, as well as prolonged 
rehabilitation periods [11-13].  Limited supply of autografts makes it difficult to 
repeat the surgery once the grafts fail again. Allografts are tissues obtained from 
cadavers such as patellar tendon, hamstring tendon and Achilles tendon [7, 14]. 
There are several advantages of using allografts. It does not require an additional 
surgery for tissue harvest and there is also no limit to the supply of graft tissue. 
The concern is that it may transmit diseases, cause bacteria infection and elicit 
immunogenic response on the receiver, and the sterilization of allografts will alter 
the mechanical properties of the tissue [8, 15-17]. Xenografts are tissues taken 
from animals. Early studies showed that bovine xenografts cross-linked with 
glutaraldehyde were potent candidate for ACL repair. However, recent studies 
failed to reproduce these early findings, and bovine xenografts did not obtain 
Food and Drug Administration (FDA) approval due to occasional recurrent 
effusion, graft failure and synovitis [16, 18]. 
Attempts have also been made to use synthetic materials in ligament 
replacement, but limited success was obtained [19, 20]. The first generation of 
ACL prostheses used non-degradable synthetic materials including 
polytetrafluorethylene (Gore-Tex), polyester (Dacron), carbon fibers, and 
ligament-augmentation devices (LAD) made of polypropylene [21-24]. Although 
these synthetic devices are able to provide mechanical augmentation at the 
beginning, they failed over longer duration because they cannot duplicate the 
mechanical behavior of native ligament [9, 25]. Repeated elongation of these 
devices leads to permanent deformation at the points of stress. Contact with sharp 
edges of  the  bone  tunnel  causes abrasions, which weaken the implant and create 
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debris that can cause synovitis in the joint [24]. Of 855 prosthetic ligaments 
tracked for 15 years, 40% to 78% failed due to wear debris, tissue reactions and 
mechanical limitations [26]. 
To develop a successful prosthesis for injured ACL, it is essential to 
understand the anatomy of normal ACL and the relationships between its structure 
and function. It is the complex and unique geometry that gives ACL its special 
profile of mechanical properties. ACL connects the femur and tibia. It mainly 
consists of paralleled collagen (type I, III and V) bundles which are regularly 
oriented and cross-linked to one another [27]. ACL fibroblasts attach to individual 
collagen bundles and elongate along the axis of the bundles [28] (Fig 1.1). The 
functions of cells include synthesizing fibrillar collagen and enzymatically 
degrade and clear old collagen in a renewal process [27]. Other components of 
ACL include elastin, proteoglycans and water [9]. The collagen bundles have a 
hierachical structure with different levels of organization, from collagen 
molecules, fibrils to fiber bundles and fascicles which are parallel to the long axis 
of the ligament [29, 30] (Fig 1.1). It is believed that the unique helical 
organization of collagen fiber bundles is essential for the ligament to stabilize the 
knee joint. The collagen network is twisted by nearly 180° between the two 
attachment sites at femur and tibia [29] (Fig 1.2). During flexion, the collagen 
fibers of ACL remain isometric in length, which makes the load evenly distributed 
on all fiber bundles and thus maximize the strength applied on the tissue [21] (Fig 
1.2). A successful replacement for ACL should try to mimic the isometric nature 
of ACL fibers; otherwise the length of fiber would be largely increased during 
action and become easier to rupture. The crimp fibers of ACL permit 7-16% of 
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creep before permanent deformation and ligament damage occur. Due to this, 
ACL is able to sustain high load at all degrees of knee joint motion [27]. 
Fig 1.1 Schematic diagrams of the structure of tendons and ligaments [31]. 
 
 
Fig 1.2 (A) Normal ACL at extension and flexion; (B) torn ACL. (The two pictures 
were taken from http://www.hughston.com/hha/a_11_3_1.htm). 
 
When subjected to strain, ligaments exhibit a stress-strain behavior of 
three phases, which is highly related with the arrangement of collagen in the tissue 
[32]. At low levels of stress, the force is transferred to collagen fibrils and causes 
lateral contraction between the fibrils, along with release of water and 
straightening of the crimp pattern of the fibrils. On the stress-strain curve, this is 
represented by a low value of stress per strain, which is called the toe-region [29]. 
When the levels of stress increase, the force directly stretches the collagen triple 
A B
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helix and leads to inter-fibrillar slippage between cross-links. This is represented 
as a linear region on the curve, the slope of which is the elastic modulus of the 
tissue [33]. As the levels of stress continue to increase, collagen fibers in the 
ligament fail with irreversible deformation, represented by the yield and failure 
region with a slight decrease in stress per strain [31] (Fig 1.3). 
 
Fig 1.3 Typical stress-strain curves of tendons and ligaments [32]. 
 
The average length and cross-sectional area of human ACL are 27-32mm 
and 44.4-57.5 mm2, respectively [21, 34]. Generally, standard mechanical 
parameters for ACL grafts are 1730 N of tensile strength, 182 N/mm of linear 
stiffness, 12.8 N-m for energy absorption at failure point and cyclic loads of ~300 
N for about 1.5 million times per year [21].  These parameters must be considered 
seriously into the design of prosthesis, for any mismatch of mechanical properties 
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with normal ACL may cause ultimate failures of the prosthesis. For example, if 
the prosthesis has a linear stiffness much higher than normal, it may cause stress 
shielding which tends to place most of the physiological load on the prosthesis 
alone, not the neo tissue. The lack of mechanical stimulus impedes collagen 
alignment which may change the dynamics of continuous tissue remodeling to 
degradation and thus weaken the mechanical strength of the neo tissue. 
The complex structure and unique mechanical properties of ACL form a 
great obstacle for developing a successful ACL replacement.  Other structural 
factors are also responsible for the difficulty of the task. The ACL is encapsulated 
by a synovium-containing fluid which serves to lubricate the joint and prevent 
clots [35]. This enables the intra-articular environment very low capacity for 
tissue healing [21]. The healing process is also inhibited by limited access to 
blood supply after injury. A vascular network extends from bone attachment sites 
and gets through the ACL to provide nourishment for the ligament. Since the 
angiogenesis usually occurs at 12 weeks after implantation, the graft is dependent 
on the synovial fluid for nutrient and metabolite exchange at the beginning of 
healing process [36]. The limited diffusion and transportation of materials always 
lead to necrosis of the tissue in the inner part [37]. Therefore, it is also important 
to find ways to improve the blood supply situations during tissue healing process 
and try to promote angiogenesis within the ligament. VEGF has been reported to 
enhance blood supply and further research could be focused on incorporating it 





1.2 Tissue engineering approaches for the ACL reconstruction 
In the first part of this chapter, a brief review was given about the 
advantages and shortcomings of biological and synthetic ACL prosthesis. Those 
aforementioned limitations have motivated a growing interest in tissue engineered 
solutions for ACL reconstruction. Tissue engineering is a multidisciplinary field. 
It incorporates the principles of biochemistry, engineering and material sciences to 
develop substitutes for injured or diseased tissues [40]. Despite a relatively short 
history of development compared with other classic research fields, researchers in 
tissue-engineering have made many achievements and more and more studies are 
on-going. In the late 1980s, Vacanti, et al. described the potential use of tissue-
specific cell transplantation on biodegradable polymer matrices to regenerate 
tissues and organs in vivo [41]. After then, numerous studies were triggered and 
the scope of this technology was expanded by more disciplines. Today, tissue 
engineered replacements are being developed for a variety of tissues, including 
nerve, skin, cardiac valves, myocardium, hepatic tissue, pancreas, bladder, as well 
as tendons and ligaments.  
There are three key elements in tissue engineering to develop functional 
neo-tissues: cells, biocompatible scaffolds and regulatory signals (biochemical 
and physical). The three components interact with one another to form a 
functional tissue-engineered system. Reparative cells are able to proliferate and 
synthesize extracellular matrix; the structural scaffold facilitates the cell functions; 
an environment provides the cells with sufficient nourishments and suitable 
regulatory systems [40]. A tissue engineered ligament can be developed in vivo or 
in vitro. For in vivo ligament development, the scaffold must be able to encourage 
cell in-growth and neo tissue formation when implanted into the host, facilitated 
by autograft or allograft donor cells. For in vitro tissue engineered systems, where 
the natural physiological environment for ligament growth and repair is absent, 
necessary stimulations need to be applied by devices such as a bioreactor to 
induce seeded cells to synthesize more extracellular matrix. In both models, it is 
essential that the neo ligament has the mechanical and biochemical properties 
necessary for supporting post-operation activities. Therefore, the primary goal of 
current research is to find the optimal combinations of the three constituents in 
both in vitro and in vivo systems. 
To be an ideal cell source for ACL regeneration, a cell lineage should be 
sufficient and readily available, proliferate robustly and possess the potential to 
elaborate extracellular matrix in an organized pattern. Other requirements include 
a good affinity to the scaffold used and adequate susceptibility to biomedical and 
mechanical regulatory stimulations. Prompted by the need of defining a suitable 
cell source for ACL tissue engineering, a wide range of cell types have been tested 
in the laboratories. 
In the past, fibroblast cell lines have been the focus of research. Fibroblasts 
are differentiated cells and they are thought to have the necessary characteristics 
for collagen synthesis. In an early investigation by Dunn et al., ACL fibroblasts 
and patellar tendon fibroblasts of rabbit were found to be able to attach, proliferate 
and synthesize collagen in vitro on a collagen fiber ligament analog [42]. Both cell 
types synthesized 10-fold greater collagen on the ligament analog than on tissue 
culture plastics. Bellincampi et al. implanted fluorescently labeled autogenous 
ACL fibroblasts on a collagen ligament analog in rabbit models [43]. The ACL 
fibroblasts remained viable in the rabbit knee for 6 weeks after implantation. ACL 
and  MCL  fibroblasts  were  shown  readily  attached  to a synthetic polymer fiber 
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scaffold and produced matrix to surround the scaffold. By 5 weeks, the scaffolds 
became single bundles of tissue and cell proliferation was promoted by 
mechanical stimulations. In these early findings, fibroblasts from various tissues 
exhibited capability of proliferation, synthesis of extracellular matrix and 
sensitivity to external stimulations, and thus were regarded as a potential cell 
source for ligament repair. However, the relatively quiescent nature of fibroblasts 
limits their potential of further differentiation, which prompted the attempts to 
find a more suitable cell source for ligament tissue engineering. 
Bone marrow stem cells (BMSC) are pluripotent progenitor cells with self-
renewal ability and potential to differentiate into various mesenchymal cell 
lineages. The cells are easy to harvest from hosts and their proliferation and 
matrix synthesis systems are robust. In a comparative study of BMSCs and 
fibroblasts, BMSCs showed the highest DNA content and collagen production 
when seeded on a suture material for 12 days [44]. BMSCs are usually collected 
from patients’ bone marrow. For most patients, this procedure doesn’t involve 
significant trauma or the risk of immune reaction [21]. A large amount of BMSCs 
can be easily obtained from in vitro cell culture and the cells are susceptible to 
external stimulations. Liechty et al. showed that human BMSCs demonstrated 
site-specific differentiation into chondrocytes, adipocytes, myocytes and 
cardiomyocytes in a sheep fetus [45]. In several studies by Altman et al., both 
mechanical stress and growth factor were proven to help induce fibroblast 
differentiation of BMSCs [46-48]. The success of aforementioned research, along 
with  many  others, established  the  role  of  BMSCs   as  a  promising  cell  
source  for  ACL  tissue engineering.  More tests will be done to fully understand  
the   characteristics   of  BMSCs   and   the   utility   of   other   pluripotent   cell 
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lineages such as neonatal, periosteal and adipose-derived stem cells will also be 
explored. 
The constitution and structure of biodegradable scaffold is another crucial 
factor for the success of ligament tissue engineering. The scaffolds not only 
provide support for tissue growth, but also influence the transport of nutrients, 
metabolic wastes, as well as applied regulatory signals [21]. The requirements for 
a suitable scaffold include capability of supporting cell adhesion and proliferation, 
being biocompatible with the recipient, appropriate degradation rate in vivo and 
importantly, sufficient initial strength to withstand tensile load. A wide range of 
materials have been tested, among which collagen and synthetic polymers have 
been explored with the greatest interests.  
Collagen has been clinically used as suture material and clotting 
accelerators for decades. Since the extracellular matrix of ACL is mainly 
composed of collagen, scaffold made of collagen is for sure considered best 
mimic the structural framework of native ACL. Fibrous collagen scaffold was 
demonstrated to support cell attachment, proliferation and extracellular matrix 
production [42, 43]. However, they failed to meet the mechanical requirements for 
an ACL replacement.  As the collagen bundles are cross-linked to each other in 
normal ACL, collagen grafts were cross-linked with chemicals or ultraviolet to 
reduce their degradation rate before use. In addition to the insufficient mechanical 
strength, collage grafts also have biocompatibility problems when implanted in 
vivo. Implantation of bovine collagen grafts in human articular environment has 
resulted in profound immunogenic reactions and graft rejection [49]. Although 
collagen is still being tested as a potential biomaterial for ligament replacement, 
its mismatches of mechanical properties with normal ACL, as well as the 
biocompatibility concerns, have limited its utility in ligament tissue engineering. 
Biodegradable synthetic polymers are another choice for ligament scaffold 
fabrication. They are commercially available and biocompatible. They can be 
gradually reabsorbed and replaced by tissue in-growth, with minimal possibilities 
of inflammatory reactions. Most of these polymers are approved for clinical 
applications and possess reliable clinical records. Synthetic polymers are a large 
family of materials. By choosing different polymers, researchers are able to 
fabricate scaffolds with desired mechanical properties, degradation rate and 
cellular response. Laurecin et al. developed a 3-D braided poly (lactic-co-glycolic 
acid) (PLGA) with different pore sizes at the bony attachment and intra-articular 
portions of the graft, in the hope that bone and ligament growth can be 
preferentially enhanced [50]. Both ACL fibroblasts and murine fibroblasts 
proliferated on the scaffold. In another study, a 3-D braided scaffold made of poly 
(L-lactic acid) (PLLA) coated with fibronectin (a cell-adhesion molecule) 
potentially improved cell proliferation and long-term mechanical properties of the 
construct compared with PLGA, suggesting it a more suitable choice for ACL 
tissue engineering [51]. 
In addition to collagen and synthetic polymers, molecules such as chitosan, 
alginate and hyaluronic acid are also being considered as potential ACL scaffold 
material [52-56]. These materials are intrinsically biocompatible and able to 
support cell adhesion and growth. So far, there are few studies reporting the 
functions of scaffolds made of these materials. More explorations will be 
necessary to better understand the properties and potentials of these materials for 
tissue engineering applications. 
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Biochemical and mechanical regulations are essential for developing a 
functional ACL prosthesis. For biochemical regulatory signals, most studies are 
focused on the effects of various growth factors on cell proliferation and 
differentiation. Molecules such as epidermal growth factor (EGF), insulin-like 
growth factor-II (IGF-II), transforming growth factor-beta (TGF-β) and fibroblast 
growth factor all have the capability of increasing cell proliferation and 
extracellular matrix production [57-65]. What’s more, insulin, TGF- β and IGF-II 
promoted protein expression and extracellular production in soft tissues [62, 66]. 
Serum, the supplementary component for most cell culture medium, contains a 
variety of stimulators for in vitro cell growth and differentiation, including amino 
acids, growth factors, vitamins, proteins, hormones, lipids and minerals, as well as 
protein inhibitors of cell differentiation. Moreau et al. suggested 3 formulas for 
cell culture that enhanced fibroblast differentiation: (1) EGF and TGF, (2) bFGF 
and TGF, and (3) growth factor-free advanced Dulbecco’s minimal essential 
media (ADMEM) [48]. In addition to supplementing these factors in cell culture 
medium, they can also be incorporated into scaffold fibers and released with 
controlled profiles. Non-biomedical factors such as oxygen can also greatly affect 
extracellular matrix production rates [67, 68].  Fermor et al. showed that oxygen 
can reversely affect cell proliferation and extracellular matrix production. A high 
oxygen tension (21%) promoted ACL fibroblast proliferation, whereas a lower 
tension (10%) enhanced collagen synthesis [69]. Though numerous studies have 
been made to determine the effects of these regulatory factors on ligament tissue 
engineering system, little is known about their regulatory mechanisms, as well as 
the correct concentration and timing. Future investigations will explore more to 
find answers for these questions.  
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It has been proven that exercise and dynamic loading improve ligament 
strength whereas long time of immobilization adversely affects ligament’s 
ultimate failure strength [70]. Since physiological strain is necessary for 
maintaining tissue strength, it is crucial to provide developing tissues with 
appropriate mechanical stimulations. A study by Altman et al. showed that 
multidimensional mechanical strains (translational and rotational) up-regulated 
ACL related markers expression of undifferentiated cells in a collagen gel [46]. 
Moreover, significant cell alignment and formation of oriented collagen fibers 
were also observed. Meanwhile, no bone or cartilage specific markers were 
observed. In a newly developed bioreactor system by the same group, more 
regulatory factors were added, all controlled by computer. In addition to the 
mechanical strain profiles, dissolved oxygen tension between 0 - 95% was applied 
to the developing tissue. The fluidic control was also improved. Cell spreading, 
growth and differentiation into ligament-like cells on a silk matrix were all 
observed after 21 days of incubation in this bioreactor system [47]. 
Mechanical signals affect developing tissues in at least two ways: first, 
they enhance the mass transportation of nutrients and metabolite wastes; second, 
they directly influence cells through mechanical signal transduction pathways [21]. 
Further investigations will be necessary to fully understand the mechanisms 
through which mechanical signals affect tissue development, and it will be of 
great help if a whole set of quantitative analysis of the optimal stimulus for tissue 




1.3 Silk as a biomaterial in biomedical applications 
Silk from the silk worm, Bombyx mori, has been used commercially as 
biomedical sutures for quite a long time [71]. In recent years, the studies on silk 
fibroin have increased more and more for new biomedical applications due to its 
biocompatibility, slow degradation rate and superior mechanical properties [72]. 
The proteins of this family have relative high environmental stability compared 
with globular proteins which have catalytic and molecular recognition functions 
[71]. In addition, there are various options for genetic control to tailor the 
sequence of this protein, which has expanded the utility for this natural protein in 
a wide range of biomaterial and tissue engineering applications. Silk fibroin in 
various formats (films, fibers, nets, meshes, membranes, yarns and sponges) has 
been made as promising scaffolds for engineering a number of tissues like bone, 
ligament, cartilage and skin.  
Silkworm silk from the cocoon of B. mori consists of two major fibroin 
proteins, the light and heavy chains, molecular weights of which are 25 and 325 
kDa, respectively. These core fibers are coated with a layer of sericin, a family of 
glue-like proteins that holds two fibroin fibers together to form the composite 
fibers of the cocoon case. Silk fibroin proteins have significant homogeneity in the 
secondary structure - β-sheet. This is due to the proteins’ highly repetitive primary 
sequences.  Alanine-glycine repeats with serine or tyrosine are the core sequence 
repeats in the fibroin heavy chain from B. mori. Silk fibers are environmentally 
stable in comparison to globular proteins, due to their extensive hydrogen bonding, 
the hydrophobic nature of most of the proteins and a large amount of crystal 
structures. The proteins possess oriented and numerous β-sheet crystals, a fuzzy 
interphase between these crystals and the less crystalline domains. All these 
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structural components as well as the shear alignment of the chains, form the basis 
of the novel mechanical properties exhibited by silk fibers. A comparison of 
mechanical properties shows that the ultimate tensile strength and modulus of B. 
mori silk fibers are much higher than those of other commonly used biomaterials 
such as collagen, cross-linked collagen and PLA [73-75]. 
The most extensive utility of silk fibers was sutures for wound ligation. 
Their reliable quality made them the most common natural suture in the last 100 
years, surpassing collagen as a biomaterial in the biomedical industry [76]. At the 
same time, however, some reverse biological responses to the material have been 
reported, raising questions on the biocompatibility of this material. Many studies 
were attempted and the glue-like sericin proteins were found to be the primary 
cause of adverse problems regarding the biocompatibility and hypersensitivity to 
silk [77-80]. Clearance of sericin from the surface of silk fibers provided a 
solution to these biocompatibility problems and several studies showed that the 
biological responses to the sericin-free core fibroin fibers appeared to be 
comparable to most other commonly used biomaterials [81, 82]. There were two 
types of silk used as sutures in the past, the virgin silk (silk containing sericin) and 
black braided silk (sericin-free silk fibroin coated with waxes or silicone). Though 
in many clinical studies the type of silk suture used was not specified, a number of 
findings showed that the adverse biological responses were related with virgin silk, 
not the black braided one. Wen et al. performed skin tests on 64 children who 
suffered from asthma [83]. The extracted sericin was found to be responsible for 
sensitization (the development of a T-cell mediated allergic response) of these 
patients. In a study conducted by Soong and Kenyon, 12 patients who reported 
severe reactions to virgin silk sutures after cataract surgery were traced from 1980 
to 1983 for the details of their clinical problems [84]. These patients were 
successfully treated by replacing the virgin silk with 10-0 nylon sutures.  By 
means of immunoblot technique, Dewair et al. found that IgEs were up-regulated 
in response to sericin [85]. In contrast, no similar reactions were found when 
black braided silk sutures were used. All these studies confirmed it is these fibroin 
contaminants that are the main allergenic agent in silk, not the core fibroin 
proteins.  
In the past, silk was regarded as a non-degradable biomaterial. However, 
this is a misconception. According to the US Pharmacopeia the definition of an 
absorbable suture biomaterial is one that “loses most of its tensile strength within 
60 days’ post-implantation in vivo” and it is correct to classify silk as non-
degradable biomaterial based on this definition. However, a number of studies 
showed that silk is able to degrade but needs longer time periods [84, 86-88]. This 
is because proteolytic degradation of silk is usually mediated by foreign body 
response. To all suture materials, it is common to require inflammation as the 
main mechanism of degradation [71]. Lam et al. found that silk was susceptible to 
proteolytic enzymes [88]. Black braided silk sutures began to degrade after 2 
weeks in vivo and severe fragmentation at 6 and 12 weeks in vivo made it difficult 
to retrieve the silk sutures. Therefore they described silk as a biodegradable 
material. Altman et al. showed increasing fragmentation of silk fibers within 7 
days of incubation with 1mg/ml protease XIV [89]. Degradation of silk can be 
tested by the loss of mechanical integrity. Greenwald et al. compared mechanical 
properties of six absorbable sutures and four non-absorbable sutures after 
implantation circumferentially under the skin of rats. After 6 weeks of surgery, 
silk lost 55% of its tensile strength and 16% of its elastic modulus [90].  In a study 
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conducted by Bucknall et al., silk sutures were implanted subcutaneously in a rat 
model. Silk fibers lost 29% of their tensile strength at 10 days, 73% at 30 days and 
83% at 70 days post implantation [81]. In vitro studies have shown that protease 
cocktails and chymotrypsin are able to enzymatically degrade silk fibers. 
Chymotrypsin which is originated from macrophages will cleave the less-
crystalline regions of the fibroin protein to peptides which are capable of being 
phagocytosed for further metabolism by the cell. Silk degradation is rather slow in 
vivo. It is generally believed that silk fibers lose the majority of their tensile 
strength within 1 year in vivo and completely degrade at the site within 2 years 
[91]. Other factors including the in vivo implantation site, the mechanical 
environment and the health and physiological conditions of the patient are also 
able to influence the degradation rate of silk [84, 87, 91]. Some processing 
methods of silk fibers may cause conformational changes in fibroin protein 
structure, which potentially increase or decrease the susceptibility of silk to 
enzymatic degradation. So far, no studies have been attempted to explore the 
effect of these factors on silk degradation process in details; therefore, it is 
difficult to gain a clear view of the relationships between silk structure, external 
environment and silk degradability.  
Several studies show that sericin-free silk fibroin is able to support cell 
attachment, spread and proliferation. In a study by Inouye et al., a silk fibroin film 
exhibited equivalent ability with collagen in terms of supporting animal cell 
growth after 5 days in cell culture conditions [92]. Minoura et al. drew a similar 
conclusion when they compared cell attachment growth on both silk and collagen 
films [93]. Moreover, silk fibroin offers various possibilities in scaffold design for 
a number of tissue engineering applications. This characteristic made silk a 
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popular candidate in tissue engineering of bone, cartilage, tendons and ligaments, 
as well as blood vessels. Silk fibroin can be processed into different forms of 
matrix using a number of experimental techniques. Silk solutions were cast into 
films for wound dressing and skin repair [93]. In the presence of acid, ions or 
other additives, silk solution was transformed into hydrogel for bone and cartilage 
repair, as well as drug release and delivery [94]. Fiber deposition and 
electrospinning were used to make non-woven silk net for tissue engineering 
usage [95, 96]. 3-D porous silk sponge was made by salt leaching, gas foaming 
and freeze-drying methods for cartilage repair and regeneration [97, 98]. Silk 
fibers can also be modified to obtain better biocompatibility. In a study by Altman 
et al., the silk fiber surfaces were coated with RGD sequence and both cell 
proliferation and extracellular matrix production were enhanced a lot [54]. In the 
field of ACL tissue engineering, a study of Kaplan’s group fabricated a six-cord 
silk matrix based on silk fibers. To reduce the high linear stiffness of silk fibers, a 
geometry involving different hierarchies was chosen as the design which mimics 
the natural structure of ACL collagen bundles. Several mechanical parameters of 
the matrix such as maximal tensile load, linear stiffness were very close to those 
of normal human ACL. The matrix was also proved to support bone marrow stem 
cells adhesion and proliferation [99]. Based on these achievements, more attempts 







1.4 Review of previous work in Prof. Goh’s lab 
Tissue engineering approaches to the repair and regeneration of tendons 
and ligaments have been one of the main research interests in the lab for years and 
a number of findings and achievements have been made through the efforts of lab 
members and the assistance of lab collaborators. The research mainly focused on 
understanding the role of different cell sources in tendon and ligament repair, the 
properties and functions of various biodegradable materials and developing new 
techniques for scaffold fabrication. A brief review of the previous work in the lab 
will be given as they served as an important part of the theoretical basis of the 
project to be presented in the next chapters. 
A suitable cell source is a key factor for the development of a successful 
tissue engineered ACL. Several studies were made in the lab to compare different 
cell lineages as potential cell source for tendon and ligament repair. Ge et al. 
compared the ease of isolation, proliferation and collagen production of ACL 
fibroblasts, MCL fibroblasts and rabbit BMSCs [100].  In this study, it is shown 
that BMSCs were reliable cell source while the number of ACL fibroblasts and 
MCL fibroblasts acquired from digestion of tissues were not stable. BMSCs were 
able to maintain typical fibroblast-like morphology before passage 2 and 
proliferated quite well. Regarding the production of collagen I, collagen III and α-
actin, BMSCs had similar properties with ACL and MCL fibroblasts. Besides in 
vitro study, there were also in vivo studies to examine the role of BMSCs in 
tendon and ligament repair field. Ouyang et al. demonstrated that BMSCs 
remained viable for prolonged periods after implantation in a rabbit model and 
conclusion was drawn that the cells have the potential to influence the formation 
and remodeling of neo-tendon tissue after tendon repair [101]. They created a 
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window defect at the central portion of rabbit patella tendon and treated it with 
GFP or CFDA marked BMSCs using fibrin glue. The rabbits were sacrificed at 
designated time points, and samples were observed by confocal microscopy. It 
was found that the seeded BMSCs remained viable within the wound site for at 
least 8 weeks, with the morphology of a spindle shape from 5 weeks post surgery. 
Moreover, Ouyang et al. implanted a large number of BMSCs to the bone tunnel 
in a tendon graft for the repair of rabbit ACL, and it was found that the insertion 
healing of tendon to bone was greatly improved at early time points through 
formation of fibrocartilagenous attachment [102]. In another study by Lim et al., 
the tendon grafts were coated with BMSCs and the quality of graft 
osteointegration in ACL reconstruction was evaluated [103]. By 8 weeks, a 
mature zone of cartilage was observed gradually blending from bone in to the 
tendon grafts coated with BMSCs, while in control group only mature scar tissue 
was seen spanning the tendon-bone interface. As to the biomechanical properties, 
BMSCs-enhanced group also had significantly higher failure load and stiffness 
compared with control group. 
Besides the research on suitable cell sources, a number of studies were 
made to find a satisfactory biodegradable scaffold for ACL repair by testing their 
functions in vitro and in vivo. Ouyang et al. compared the attachment, 
proliferation and morphology of rabbit ACL fibroblasts and BMSCs on seven 
degradable films made of different synthetic polymers [104]. Among those films, 
the film made of high molecular weight PLGA was shown to have the best 
capability of encouraging ACL fibroblasts and BMSCs to attach and proliferate. 
The results were comparable with those on tissue culture polystyrene. After that, 
an in vivo study by Ouyang et al. in a rabbit model used knitted structure of 
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PLGA loaded with allogeneic BMSCs to repair a gap defect of Achilles tendon 
[105]. Four weeks post operation, the construct exhibited a high rate of tissue 
formation and remodeling and the wound sites healed well with no apparent 
lymphocyte infiltration. Ge et al. fabricated a knitted scaffold using fibers of two 
polymers - PLGA and PLLA – in the hope to improve the mechanical properties 
of the construct [106]. In addition to donor cell loading, fascia lata was harvested 
from the rabbit during surgery as a wrap to mimic the synovium of native ACL. 
After implantation of 20 weeks in a rabbit model, both the donor cell seeding and 
the fascia wrap were shown to promote synthesis of collagen I and III, and fascia 
wrap seemed to have a stronger effect. However, the mechanical properties still 
remains the main problem with this polymeric scaffold. The constructs with both 
cells and fascia wrap got the highest tensile load among the four experimental 
groups, which is only 20.9 ± 4.5 N, much lower than the 151.8 ± 20.8 N of native 
ACL. The stiffness of the constructs is 8.4 ± 2.2 N, whereas native ACL has a 
stiffness of 50.4 ± 5.3 N. Neither donor cells nor fascia wrap can improve the 
mechanical properties of the grafts. 
Though some achievements have been made, problems remained in 
finding a suitable biomaterial and a better fabrication method for the scaffold in 
ligament repair. These problems prompted the planning of the project to be 
presented, and what’s more, provided valuable information and experience for the 





1.5 Aim and scope of the project 
Discussions in the preceding sections indicate the requirements of a 
biomaterial in the application of ACL tissue engineering and suggest that silk 
fibers might be a potential candidate. The aim of the project presented in the 
following chapters is to design and fabricate a novel 3-D silk scaffold and 
evaluate its function both in vitro and in vivo. The project consists of three parts: 
(I) Design and fabrication of the silk scaffold. The fabrication procedures 
were optimized followed by basic characterizations of the scaffold.  
(II) In vitro studies of the silk scaffold. The scaffold’s ability to support 
cell attachment, proliferation and differentiation was tested. Human or rabbit bone 
marrow stem cells were used as the cell source and fibrin glue were used as the 
control delivery system of cell seeding.  
(III) In vivo studies of the silk scaffold. The scaffold’s function was tested 
in New Zealand White Rabbit. The silk scaffold seeded with rabbit bone marrow 
stem cells was implanted in the knee joint of rabbit leg to replace its normal ACL. 
Samples were harvested 4 weeks later and mechanical and biochemical analysis 
were performed on the samples to evaluate the development of neo tissue. Silk 
scaffold without cells were used as control. 
Through this project, tissue engineering principles and applications are to 
be understood better. Useful information regarding the scaffold’s properties and 
functions will be provided and recommendations and suggestions for future work 




Materials and Methods 
 
2.1 Processing of raw silk fibers 
Raw Bombyx mori silk fibers were kindly provided by the Silk Innovation 
Center of Mahasarakham University, Thailand. Each silk fiber contains 80 silk 
fibroin filaments which are hold together by sericin, the gum-like protein on the 
surface of silk fibers. To get rid of sericin, silk fibers were immersed in 0.2 % 
(w/v) aqueous Na2CO3 solution at 95°C for 1.5h. The solution was agitated 
occasionally to help fully remove sericin. After processing, silk fibers were 
thoroughly washed with distilled water and dried in room temperature. Complete 
removal of sericin was verified by scanning electron microscope (SEM) 
observation. 
 
2.2 Preparation of silk fibroin aqueous solution 
10% (w/v) of silk fibroin aqueous solution was made by dissolving sericin-
free silk fibers in a mixture of CaCl2-C2H5OH-H2O (molar ratio 1:2:8) in 78°C 
water bath for around 2h. The resulted solution was then dialyzed against Milli-Q 
water using SnakeSkin pleated dialysis tubing (3500 MWCO, pierce). The precise 
concentration of silk solution was determined as follows: 5ml of silk solution was 
freeze-dried to remove all the water components in it and the resulted solid silk 
was weighed. The concentration (w/v) of the solution was obtained by dividing 
the  weight  by  the initial  volume of the solution.  A less concentrated silk fibroin 
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solution was prepared by diluting it with distilled water. After the procedures, silk 
fibroin solution was kept at 4°C till use. 
 
2.3 Fabrication of 3-D silk scaffold 
The main frame work of the 3-D scaffold was knitted out of one yarn of 
raw silk fibers containing 80 silk fibroins using a 12-needle knitting machine (SK 
270, Silver Reed, Suzhou Harisa Machinery Co., China) (Fig 2.1). The knitted 
scaffold was then mounted on a custom-made U-shaped K wire (1mm diameter) 
frame with a dimension of 2.5 x 3 (cm) and processed using the aforementioned 
protocol to remove sericin. After processing, the scaffold was washed thoroughly 
with distilled water, dried at room temperature and placed in a petridish. Complete 
removal of sericin on the knitted scaffold was confirmed by SEM observation. 
10ml of 1% (w/v) silk fibroin aqueous solution was added to immerse the knitted 
scaffold in petridish. The mixture was placed in Wizard 2.0 control system (VirTis 
Model, SP Industries, NY) and freeze-dried for 36h. The freeze-drying program 
was as follows: 
(1) Freezing phase: shelf temperature at -20°C for 12h; 
(2) Intermediate phase: shelf temperature at -35°C, condenser temperature 
at 40°C, holding for 5min, vacuum 200 millitorr; 
(3) Drying phase I: shelf temperature at 0°C for 12h, vacuum 100 millitorr; 
(4) Drying phase II: shelf temperature at 20°C for 12h, vacuum 100 
millitorr. 
After freeze drying, the resulted 3-D silk scaffold was treated with 100% 




2.4 Characterization of the scaffold 
2.4.1 Scanning electron microscopy (SEM) 
Raw silk fibers, processed silk fibers, processed knitted scaffold and 3-D 
silk scaffold were collected, sputter coated with gold and their morphologies were 














Fig 2.1 Pictures of the knitting machine (A) an overall look of the machine; (B) a 
close-up view of the knitting head of the machine. 
 
2.4.2 Swelling properties 
Swelling ratios of the 3-D silk scaffold in distilled water were determined 
to evaluate its swelling properties. Firstly, the scaffolds were cut into pieces which 
fit the well of 24-well multi-plate and immersed in distilled water for 24h at room 
temperature. After that, the excess water was removed with paper towel and the 
wet weight of the scaffold determined. The scaffolds were then dried in 37°C oven 
overnight and the dry weight of the scaffolds was measured. The swelling ratio 
(ESW) was calculated as follows: 
ESW = [(We-Wo)/ Wo] X 100 
Where We indicates the weight of specimen at equilibrium swelling, Wo 





2.4.3 Mechanical properties 
Mechanical properties of the 3-D silk scaffold were evaluated by a simple 
pull-to-failure test using a universal testing machine (Instron 5543 tester, Instron 
Inc., MA). Briefly, 3-D silk scaffold was made out of 12-needle knitted scaffold 
and coated with silk sponge. 12-needle knitted scaffold without freeze-dried silk 
sponge coating was used as control. Five samples in both groups were tightly 
rolled up and two ends sealed (Fig 2.2A). Before test, specimens in both groups 
were moisturized with 1 x PBS and spotted dry on paper towel. Gauge length of 
specimens was 20mm and cross-head moved at a speed of 10mm/min (Fig 2.2B). 
Tensile load (N) and extension (mm) were recorded and a curve of load versus 
extension was plotted. The ultimate tensile load (N), strain at break (%) and 
elastic stiffness (N/mm) of the specimens were determined from the curve. The 
elastic stiffness was defined by the slope of the initial linear section of the tensile 
load-extension curve. 
 
Fig 2.2 Photographs of 3-D silk scaffold during mechanical tests (A) preparation of 
the samples (black lines indicated the clamping sites of the scaffold on mechanical 
test machine, between which is the gauge length – 20mm); (B) 3-D silk scaffold was 






2.5 In vitro tests 
2.5.1 Rabbit bone marrow stem cells isolation and culture 
Rabbit bone marrow stem cells (BMSC) were isolated and expanded by 
previously published techniques. Briefly, no more than 5ml of bone marrow was 
aspirated from the iliac crest of male New Zealand White Rabbit (~ 2.7kg). After 
centrifugation and washed by PBS (1x), nucleated cells were plated in T-75 tissue 
culture flasks, cultured in low-glucose Dulbecco’s modified Eagle’s medium 
(DMEM; Gibco, Invitrogen, CA), supplemented with 10 % fetal bovine serum, 
10,000 U/ml penicillin and 10,000 µl/ml streptomycin. The culture medium was 
changed every three days. BMSCs were kept based on their ability to adhere to the 
tissue culture plastic and non-adherent hematopoietic cells were disposed during 
medium replacement. When the primary culture of BMSCs became 80% 
confluent, they were digested with 0.25% trypsin/1mM EDTA and replated in 
tissue culture flasks. Second passage (P2) of BMSCs was used in both in vitro and 
in vivo studies. 
 
2.5.2 In vitro cell seeding on the scaffold 
For in vitro studies, 3-D silk scaffold was used as experimental group and 
sericin-free knitted silk scaffold without freeze-dried silk sponge was used as 
control group. 3-D silk scaffolds were cut into pieces to fit in 6-well or 24-well 
multiplate. Scaffolds were sterilized by autoclaving. Before cell seeding, sterile 
scaffolds were pretreated with cell culture medium in 37°C incubator overnight 
and the medium was then aspirated out. Either human or rabbit BMSCs were 
digested and resuspended in a certain volume of cell culture medium. For confocal 
imaging, 3 x 105 rabbit BMSCs (P2) were resuspended in 50µl medium and 
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simply pipetted onto the scaffold placed in 24-well multiplate; for SEM imaging, 
human BMSCs (P3) were used instead. For MTT assay and real-time PCR, 
1million human BMSCs (P2) were resuspended in 200µl medium and pipetted 
onto the scaffold placed in 6-well multiplate.  In each experiment, cells were 
allowed to attach for 4h in the incubator. After that, 3ml (in 6-well plate) or 500µl 
(in 24-well plate) DMEM were supplemented into each well containing the 
samples. For control group, cells were loaded onto the scaffold in 500 µl (in 6-
well plate) or 200 µl (in 24-well plate) fibrin glue (Baxter AG, Vienna, Austria). 
 
2.5.3 Cell viability assay 
 The viability of the cells seeded on the scaffolds was tested by 
tetrazolium-based colorimetric (MTT) assay. Samples were harvested at 
designated time points (day 2 and 14 post cell seeding). Cell culture medium was 
aspirated out and samples were rinsed with PBS, followed by adding 150µl MTT 
reagent (5mg/ml) into each well. Samples were placed in the incubator for 4h. 
After 4h, MTT reagent was aspirated out and samples were rinsed with PBS to get 
rid of MTT residues. 800µl DMSO was added into each well and the systems 
were shaken for 30min. 100µl of the solution was taken from each well, put into 
96-well and the absorbance at 570mn was measured. The experiment in both 
groups was carried out in triplicate. 
 
2.5.4 Soluble GAG assay 
Blyscan GAG assay (Biocolor, Newtownabbey, Northern Ireland) were 
used to measure the total amount of soluble sulphated glycosaminoglycan (GAG) 
secreted by cells seeded on the scaffolds into the cell culture medium. Cell culture 
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Medium was changed at day 12 post cell seeding and 200µl out of 1000µl 
medium per sample was collected at day 14 to determine the amount of GAGs 
synthesized by the cells during two days. According to the manufacturer’s 
protocol, GAG content was measured spectrophotometrically at 656nm, with 
550nm as the reference wavelength. A calibration curve was blotted using the 
GAG standard (0.1mg/ml) supplied along with the assay kit. Experiments for both 
groups and calibration curve were carried out in triplicate. 
 
2.5.5 RNA isolation and real-time PCR 
Total RNA of cells from both groups was isolated on day 7 and day 14 
post cell seeding with Trizol reagent and an RNeasy kit (Qiagen, Valencia, CA, 
USA). Since cells seeded on scaffold and within fibrin glue are difficult to digest 
by trypsin, each sample was harvested, rinsed with 1xPBS and immersed in 1ml 
Trizol to disrupt cells, followed by total RNA extraction according to the 
supplier’s instruction. Total RNA concentration was determined by optical density 
at 260nm (OD260) and the final elute was stored at -80°C. No more than 1µg of 
total RNA was used to synthesize cDNA using an Iscript cDNA synthesis kit 
(Bio-Rad laboratories, USA). The cDNA product was stored at -20°C.  
Quantitative real-time PCR reactions was carried out and monitored with a 
Stratagene Mx3000P system. QuantiTect SYBR Green PCR kit (Qiagen, USA) 
was used to quantify at transcript level the amount of ACL related molecular 
markers including collagen type I, collagen type III and tenascin-C. Primers of 
genes of interest were synthesized by Research Biolabs, Singapore (Table 2.1). 
1µl of cDNA from each sample was mixed with 12.5µl QuantiTect SYBR Green 
PCR master mix, 0.3µl of each primer and 10.9µl RNase-free water. The total 
reaction volume was 25µl. A housekeeping gene, human GAPDH was used as the 
reference transcript. All the samples were analyzed for the genes of interest and 
reference gene in independent reactions. Data were analyzed by Stratagene MxPro 
QPCR software. The Ct value was used as an indicator of gene expression in this 
system. Ct value was defined as the cycle number at which the fluorescence 
intensity reached a certain threshold where amplification of each target gene was 
within the linear region of the reaction amplification curves. Relative expression 
level of each gene was normalized with the Ct value of GAPDH using 2ΔCt 
formula (Perkin Elmer User Bulletin #2) and compared with the expression level 
at day 0 (before cell seeding). The experiments were carried out in duplicates. 
 
Primer Sequence 
Collagen-I        
forward   
 
5’- CAG CCG CTT CAC CTA CAG C – 3’ 
reverse 5’- TTT TGT ATT CAA TCA CTG TCT TGC C -3’ 
Collagen-III     
forward 
 
5’- ACA CGT TTG GTT TGG AGA GTC C -3’  
reverse 5’- CTG CAC ATC AAG GAC ATC TTC AG -3’ 
Tenascin-C       
forward 
 
5’- TCT CTG CAC ATA GTG AAA AAC AAT ACC -
3’ 
reverse 5’- TCA AGG CAG TGG TGT CTG TGA -3’ 
GAPDH           
forward 
 
5’- ATG GGG AAG GTG AAG GTC G -3’ 
reverse 5’- TAA AAG CAG CCC TGG TGA CC -3’ 
 
Table 2.1 Primer sequences for RT-PCR (human bone marrow stem cells) 
 
2.5.6 SEM imaging 
SEM  was  used  to observe  the  cell attachment  and  proliferation on  the 
3-D silk scaffold.  Briefly,  samples  were  harvested at  day  2, 7 and  14  post  
cell  seeding,  washed  with  1 x PBS  and  fixed  in  glutaraldehyde  (0.25%).  The 
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specimens were then sputtered with gold and observed with a JEOL JSM-5600LV 
model (Japan). 
 
2.5.7 FDA staining and confocal microscopy 
Samples for confocal microscopy from both groups were collected at day 2, 
7 and 14 post cell seeding. A low seeding density was used for the convenience of 
observing cell morphology changes. Samples were thoroughly rinsed with PBS 
and incubated with 6 µl FDA in 2ml PBS per well at room temperature for 10 
minutes in dark. Before viewing, samples were washed with PBS twice and cell 
morphologies were observed using a LSM 510 meta model (Zeiss, Germany). 
 
2.5.8 Statistical analysis 
All the results are expressed as mean ± standard deviation. Single factor 
analysis of variance (ANOVA) was used to assess the statistical significance of 
results between groups using OriginPro (version 6.1). Statistically significant 
values were defined as p<0.05. 
 
2.6 In vivo tests 
2.6.1 ACL reconstruction and surgical procedures 
The animal study protocol was approved by NUS Institutional Animal 
Care & Use Committee (IACUC). Eighteen skeletally matured New Zealand 
White Rabbits weighing ~2.8kg were used in this study. The animals were kept in 
Animal Holding Unit (AHU) and all the surgeries were performed in the surgery 
room at AHU. Unilateral implantation was performed on each rabbit and samples 
were harvested 4 weeks post operation.   The rabbits were divided into two groups 
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– the experimental group and the control group. For the experimental group, one 
silk scaffold with 3 million rabbit BMSCs loaded in vitro one day before the 
operation was implanted in the right leg of each rabbit (Fig 2.3B). For the control 
group, one silk scaffold without cells (Fig 2.3A) was used in each rabbit. The 
rabbits were anesthetized as follows: 0.3ml/kg hyponym was administrated intra-
muscularly to tranquilize the animal, followed by intra-venous administration of 
0.3ml/kg Valium for induction; after that, 1% halothane inhalation was used for 
maintenance; 0.3ml per animal of cephacexin was given subcutaneously as 
antibiotics after the operations. 
The operations were carried out under aseptic conditions. The knee joint of 
the rabbit was exposed by a midline skin incision and lateral parapatellar 
arthrotomy. The knee was extended and the patella was dislocated medially. With 
the knee placed in hyperflexion state, native ACL was removed by sharp 
dissection at the tibial and femoral attachment sites and the fat pad was left intact 
(Fig 2.3C). Using a 2-mm drill bit and a manual drill, bone tunnels were made 
from the anatomic ACL femoral attachment site to lateral femoral condyle, and 
from the anatomic ACL tibial attachment site to medial tibia, which is distal and 
medial to the tibial tubercle. Each end of the sterile scaffold was sutured with 2-0 
ETHIBOND EXCEL suture (Ethicon, NJ) for the ease of threading the scaffold 
through the bone tunnels. The scaffold was placed in the intra-articular space, with 
one end passed through the femoral bone tunnel and the other end through the 
tibial bone tunnel. A 2mm hole was drilled bellow the bone tunnel and the end of 
scaffold was fixed by a 2mm screw (Synthes, Switzerland) (Fig 2.3D). The rabbits 
were left in their cages without immobilization. At designated time points, the 
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rabbits were euthanized with 1ml (400mg)/2.5kg body weight of pentobabitone 
sodium, and both knee joints were dissected for histology and mechanical test. 
 
2.6.2 Histology and immunohistochemistry 
Four weeks after the operation, six rabbits were sacrificed, two of which 
were used for histology and immunohistochemistry analysis while the remained 
four were used for mechanical tests. For histology, all the other connective tissues 
in the knee joint were cleared except the ACL. The central parts of the specimens 
(without bony attachment sites) were fixed in 10% formalin overnight followed by 
normal paraffin-embedding. The samples were serial-sectioned into 5µm slices by 
a Leica RM 2135 microtome and mounted on polysine slides (Menzel-Glaser, 
Germany). Hematoxylin and eosin (H&E) staining was performed on the slides 
for histology study. For immunohistochemistry, the slides were stained with anti-
collagen type I, anti-collagen type III and anti-tenascin C monoclonal antibodies 
(Lab Vision, UK). 
 
2.6.3 Mechanical tests 
Two rabbits from experimental group and two from control group were 
used for mechanical tests while four left knees were used as control. The knee 
joints with intact capsules and femurs and tibias were harvested. All connective 
tissues and other ligaments except ACL were removed from the specimens, which 
were then sealed and kept in -80°C till use. The femur and tibia of each sample 
was embedded in a 15ml Falcon tube with dental cement and Meliodent (CE 0044, 
Heraeus Kulzer GmbH, Germany) (Fig 2.4A). The specimens were then mounted 
on Instron 5543 material testing system (Instron, Canton, MA) with a 45° flexion 
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(Fig 2.4B). Cross-head moved at a speed of 2 cm/min. The tensile load and 
elongation were measured and stiffness was determined by the slope of the load 
versus displacement plot. During the entire process, the specimens were 
moisturized with saline from time to time to avoid dehydration of the tissue. 
 
Fig 2.3 Photographs of surgical procedures (A) scaffold without cells; (B) scaffold 
seeded with cells; (C) exposure of native ACL; (D) scaffold seeded with cells was 
implanted in the knee joint of the rabbit. 
 
Fig 2.4 Photographs of specimen preparation for mechanical tests (A) specimens 
with only reconstructed ACL in the knee joint; (B) Knee joint mounted in dental 










3.1 Processing of Raw Silk Fibers 
Raw silk fibers exhibit a yellowish color due to the sericin coating on the 
surface, while processed silk fibers without sericin possess a white color. The 
surface morphologies of raw and processed silk fibers were observed by SEM. 
Before processing, silk fibroins were coated and hold together by gum-like sericin 
to form fibers (Fig 3.1A). The fibers were processed in 0.2% NaCO3 aqueous 
solution at 95°C for 1.5h and sericin was completely removed, revealing the 
smooth surface of single fibroin with an average diameter of 10µm (Fig 3.1B). 
 
Fig 3.1 SEM images revealing the change of surface morphology of silk fibroins 
before and after extraction of sericin (A) SEM image of original silk fibers; (B) SEM 
image of silk fibers after being boiled in 0.2% NaCO3 aqueous solution for 1.5h. Scale 
bars = 10µm. 
 
3.2 Preparation of Silk Fibroin Aqueous Solution 
Silk fibroin aqueous solution was prepared by dissolving processed silk in 
CaCl2-C2H5OH-H2O (1:2:8) at 78°C for around 2h, yielding a 10% (w/v) solution. 
This solution was dialyzed against distilled water and concentration was measured 
A B
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by weighing the remaining after freeze-drying. Resulted solution had a 
concentration of around 2% (w/v) and a clear white appearance (Fig 3.2). Before 








Fig 3.2 Photograph of aqueous silk fibroin solution with a concentration of 2% (w/v). 
This solution was kept in 50ml centrifuge tube at 4°C to avoid premature precipitation. 
 
3.3 Fabrication of 3-D Silk Scaffold 
After freeze-drying, silk solution formed a layer of sponge-like structure 
which filled the pores and covered the surface of knitted scaffold (Fig 3.3). The 
resulted scaffold has a white color and an average thickness of 0.538 ± 0.104 mm 
(n=5). The pore size and thickness of the scaffold was controlled by the 
concentration and volume of silk fibroin aqueous solution added. 
 
3.4 Characterization of the scaffold 
3.4.1 SEM Imaging 
The SEM images of processed knitted scaffold showed that sericin has 
been fully removed from silk fibers (Fig 3.4A, B). Knitted scaffold after freeze-
drying was coated with porous silk structure, with an average pore size of around 




Fig 3.3 3-D silk scaffold made from knitted silk scaffold and aqueous silk fibroin 
solution (A) photograph of the scaffold which was cut to fit 6-well multi-plate; (B) 
phase contrast view of the scaffold (magnification X 40), showing the porous 

















Fig 3.4 SEM images of the 3-D silk scaffold (A) & (B) SEM showed complete removal 
of sericin of knitted silk scaffold after processing in 0.2% aqueous NaCO3 solution. 
Scale bars = 200µm, 100µm respectively; (C) SEM showed the interconnected 








3.4.2 Swelling Properties 
The swelling properties of the scaffold were evaluated in the form of 
swelling ratio of the scaffold, which is 571.90% ± 142.98% calculated from the 
average of six samples. 
 
3.4.3 Mechanical Properties 
Single pull-to-failure test was performed on knitted silk scaffold and 3-D 
silk scaffold with a crosshead speed of 10mm/min. For all the tested samples of 
the two groups, the failure mode was disconnection at the root part of the scaffold 
proximal to the clamping site. As the cross-head was moving, multiple ruptures 
occurred at different parts of the samples. The ultimate tensile loads of 
experimental group and control group were 54.22 ± 3.36 N and 30.87 ± 2.32 N, 
respectively (n=5). The strain at break of the two groups were 34.90 ± 1.60 (%) 
and 154.42 ± 11.05 (%), respectively (n=5). The elastic stiffness of the two groups 
were 14.54 ± 1.15 N/mm and 2.1 ± 0.23 N/mm, respectively (n=5) (Table 3.1). 
Type of 
specimens 




54.22 ± 3.36 34.90 ± 1.60 14.54 ± 1.15 
3-D silk scaffold 
(12 needles) 
30.87 ± 2.32 154.42 ± 11.05 2.1 ± 0.23 
 
Table 3.1 Mechanical properties of 12-needle 3-D silk scaffold and knitted silk 
scaffold without silk sponge coating. * Significant difference between two groups at 
p<0.05. 
 
3.5 In vitro tests 
3.5.1 Isolation and Culture of Bone Marrow Stem Cells 
Rabbit bone marrow stem cells were isolated and cultured according to the 
most accepted protocol. After two weeks of cell culture, around 1.5 million P2 
cells were obtained in each T75 cell culture flask with typical colony-forming 
property and fibroblast-like morphology (Fig 3.5B). They grew in monolayers 
with visible nucleus and nucleolus. When cells got 100% confluent, they were 
trypsinized for in vitro studies. Human bone marrow stem cells were kindly 
provided by Prof. Lee Eng Hin’s lab (Fig 3.5A). 
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Fig 3.5 Phase control views of bone marrow stem cells (magnification X40) (A) P2 
rabbit bone marrow stem cells; (B) P2 human bone marrow stem cells.  
 
3.5.2 MTT Assay 
The cell viability was evaluated by measuring the absorbance of MTT 
reagent at 570nm. MTT assay was performed at day 2 and day 14 after cell 
seeding on 3-D silk scaffold (group II) and in fibrin glue on the knitted scaffold 
(group I). Starting from 1million human BMSCs on each scaffold, cells seeded on 
scaffold exhibited better viability than those seeded within fibrin glue at both time 
points (Fig 3.6). At day 2, the absorbance values of group I and II were 0.1276 ± 
0.0097 and 0.1779 ± 0.0255, respectively. At day 14, the values were 0.1668 ± 
0.0111 and 0.1777 ± 0.0207, respectively. Between day 2 and day 14, the viability 
of cells seeded in fibrin glue increased by 30.72% while that of the cells seeded on 
3-D scaffold remained the same (no significant difference between two time 





























Fig 3.6 Evaluation of cell viability on 3-D silk scaffold and in fibrin glue by MTT assay. 
The assay was performed at day 2 and day 14 after cell seeding. * Significant 
difference at day 2 and no significant difference at day 14 between two groups at 
p<0.05. 
 
3.5.3 Soluble GAG Assay 
Cell culture medium from both groups was changed at day 12 and 
harvested at day 14 after cell seeding, and soluble GAG content was assessed. 
During two days time, cells seeded on 3-D silk scaffold produced GAG content 
5.3 times of those produced by the cells in fibrin glue (Fig 3.7). Group I (3-D silk 
scaffold) synthesized an average of 16.74 ± 3.04µg GAGs, while group II 














Fig 3.7 Soluble GAG assay calibration curve using GAG standard (0.1mg/ml) 
supplied by Blyscan. 
 
 
Fig 3.8 Soluble GAG content synthesized in two days by cultures on 3-D silk scaffold 
and in fibrin glue. * Significant difference between two groups at p<0.05 
 
3.5.4 Real-Time PCR 
By quantitative real-time PCR, the expression levels of several ACL 
related genes were evaluated in cultures on 3-D silk scaffold and within fibrin 
glue. The experiment was performed at day 7 after cell seeding. When cultured 
with high-glucose DMEM, cells in both groups were induced to express mRNA of 






























































were expressed significantly higher on 3-D silk scaffold than in fibrin gel, 
suggesting that the former scaffold possessed a stronger function on inducing the 










Fig 3.9 Relative mRNA expression of ACL related genes by human BMSCs cultured 
for 7 days on 3-D silk scaffold and in fibrin glue. The gene expression levels are 
normalized to the housekeeping gene – GAPDH and the expression level at day 0 
(just before cell seeding). * Significant difference between two groups at p<0.05. 
 
3.5.5 SEM Imaging 
Cell attachment and growth on the 3-D scaffold were observed by SEM 
imaging. At day 2 after cell seeding, BMSCs readily attached, spread and grew on 
the silk porous structure and silk fibers (Fig 3.10A, B). At day 7 after cell seeding, 
cell numbers increased significantly with the formation of cellular extensions to 
bridge neighboring pores (Fig 3.10C, D). At day 14 after cell seeding, cell number 
increased even more and a uniform cell sheet and possible ECM covered most 
area of the scaffold, including both the porous structure and knitted silk fibers, 
indicating that 3-D scaffold supports BMSCs adherence, growing and 
proliferation (Fig 3.10E, F). 
 
 



























3.5.6 Confocal Microscopy 
The morphology of cells seeded on 3-D silk scaffold (group I) and within 
fibrin glue (group II) was compared by confocal microscopy. At day 2 after cell 
seeding, cell densities of both groups were low and cell morphology remained 
round for most cells in both groups (Fig 3.11A, B, C and D). At day 7 after cell 
seeding, most cells in group I exhibited elongated fibroblast-like morphology 
while most cells in group II remained a round or random morphology (Fig 3.12A, 
B, C and D). At day 14 after cell seeding, cell densities increased significantly in 
group I, with more cells exhibiting fibroblast-like morphology. Most cells in 
group II showed a random morphology (Fig3.13A, B, C and D). At all the three 
time points, cells seeded on the 3-D scaffold exhibited a more elongated 






Fig 3.10 SEM images showing the adherence, proliferation and cell sheet formation 
of human BMSCs on 3-D silk scaffold (A) & (B) day 2 after cell seeding; (C) & (D) day 
7 after cell seeding; (E) & (F) day 14 after cell seeding. (A), (C) and (E): scale 








Fig 3.11 Confocal images showing the difference of density and morphology of cells 
on 3-D silk scaffold and in firbrin glue at day 2 after cell seeding. (A)&(B) cells seeded 
on 3-D silk scaffold with a higher density and more elongated morphology; (C)&(D) 







Fig 3.12 Confocal images showing the difference of density and morphology of cells 
on 3-D silk scaffold and in firbrin glue at day 7 after cell seeding (A)&(B) cells seeded 
on 3-D silk scaffold with a higher density and more elongated morphology; (C)&(D) 





Fig 3.13 Confocal images showing the difference of density and morphology of cells 
on 3-D silk scaffold and in firbrin glue at day 14 after cell seeding (A)&(B) cells 
seeded on 3-D silk scaffold with a higher density and more elongated morphology; 




3.6 In vivo tests 
3.6.1 ACL reconstruction 
During the four weeks, eight out of eighteen rabbits died prematurely from 
diarrhea. Among the remaining ten rabbits, four were kept for longer implantation 
time and six were sacrificed for histology, immunohistochemistry and mechanical 
analysis. The general condition of the six rabbits was good during the four weeks. 
There were no wound infections and the constructs remained intact except that 
one construct without cells ruptured. The knitted structure of the scaffold was still 
there while most of the silk sponge structure degraded. The cartilaginous surfaces 












Fig 3.14 Tissue engineered ACL (experimental group: silk scaffold + donor cells) in 
the knee joint of rabbit right leg 4 weeks after implantation. 
 
3.6.2 Histology 
Normal ACL was comprised of paralleled collagen bundles, which were 
cross-linked to each other. ACL fibroblasts were attached to individual collagen 
bundles and elongated longitudinally (Fig 3.15). In the constructs seeded with 
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cells, scaffold was enveloped by a large number of non-parallel fibroblasts and 
some fibroblasts were found penetrated into the spaces of the scaffold. A thick 
layer of extra-cellular matrix could be seen around the scaffold, while no obvious 
parallel collagen bundles could be found under higher magnification (Fig 3.16A, 
B). In the constructs without cells, no extra-cellular matrix could be observed 




In normal ACLs, collagen I staining was much stronger than that of 
collagen III, which was stronger than that of tenascin-C (Fig 3.17). In the 











Fig 3.15 Histology of normal rabbit ACL (H&E staining, magnification x100); Scale 




































Fig 3.16 Histology of tissue engineered ACL (H&E, magnification x100) (A) 
longitudinal view of construct seeded with cells; (B) transverse view of construct 
seeded with cells; (C) longitudinal view of construct without cells; S and F indicate silk 



































Fig 3.17 Immunohistochemistry of normal ACL (magnification x100) (A) collagen I 





























Fig 3.18 Immunohistochemistry of tissue engineered ACL (construct seeded with 
cells) (magnification x100) (A) collagen I staining; (B) collagen III staining; (C) 





3.6.4 Mechanical tests 
Due to the limitation of implantation time and sample size, the results of 
mechanical tests were presented here only as a reference for future analysis of 
samples at longer time points and no statistical analysis was performed on the 
results of the constructs from control group. The failure mode of normal ACL and 
tissue engineered constructs were totally different. Of all the four normal ACLs 
tested, the failure mode was dislodgement from the bone attachment site (Fig 
3.19A). No obvious ruptures were observed on the ligament itself. In contrast, 
tissue engineered constructs from both groups ruptured from the middle part, with 
multiple minor ruptures occurring at different places simultaneously (Fig 3.19B, 
C). 
The maximal tensile load and elastic stiffness of normal ACL were 185.82 
± 26.42 N and 78.26 ± 7.13 N/mm, respectively (n=4). In experimental group, the 
maximal tensile load of the two specimens tested were 14.71%, 7.69% of normal 
ACL, respectively; elastic stiffness was 2.56% and 3.19% of normal ACL, 
respectively. In control group, two samples were harvested, one of which ruptured 
before the test. The other specimen possessed a maximal tensile load of 23.82% 




Type of specimens Maximal tensile load (N) Elastic stiffness (N/mm) 




19.33 ± 7.13 
27.34 
14.29 
4.85 ± 4.02 
2.00 
7.69 
Control (n=1) 44.26 5.25 
 











Fig 3.19 Failure modes of different specimens in mechanical tests (A) normal ACL; 










4.1 Fabrication and characterization of the scaffold 
One of the main concerns of silk fibers in tissue engineering applications is 
the gum-like sericin protein which may cause inflammatory reactions in vivo [77-
80]. Traditional method of sericin removal involves boiling raw silk fibers in 
NaCO3 aqueous solution at very high temperature. Though the high temperature is 
necessary for complete removal of sericin, it adversely affects the mechanical 
properties of silk fibers. Attempts have been made to find the most suitable 
extraction conditions in which not only the contaminating sericin is thoroughly 
removed, but the fibroin’s mechanical integrity is preserved within acceptable 
limits. Sericin was extracted in a water bath with recirculating flow (751/min) 
using temperatures from 22°C to 90°C and times from 15 to 60 min. Among all 
the regimes, the 90°C for 60 min was found the most suitable condition for sericin 
extraction. SEM showed complete removal of sericin and the majority of 
mechanical integrity was preserved, with a decrease of 15.2% in UTS and 28.3% 
in linear stiffness of a single fiber [99]. 
Our study adopted this protocol with slight amendments. Since the amount 
of sericin coated on silk fibers varies from batch to batch, 95°C - the highest 
temperature of the water bath was used to ensure complete removal of sericin. The 
extraction time was also increased to 1.5h with manual agitation from time to time 
to compensate the inadequacy of recirculation of NaCO3 solution in the water bath. 
Using this protocol, silk fibers changed appearance from a yellowish color to a 
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white color. SEM confirmed that sericin was thoroughly removed and diameter of 
single silk fibroin was reduced from over 20µm to 10µm (Fig.1C, D). The tensile 
stress and elastic modulus was decreased by 19.80% and 29.53% respectively, 
which is acceptable (unpublished results). 
Knitting has been one of the most popular fabrication methods to make 
scaffolds for ACL tissue engineering. Knitted scaffolds using biodegradable 
polymers including PLGA, PLLA and copolymers of them have been the focus of 
several studies and preliminary results showed that knitted structure of these 
biomaterials supported cell in-growth and expansion [50, 51, 105-108]. However, 
limited mechanical properties and fast degradation before the formation of neo 
tissue remained the biggest weaknesses of these scaffolds. Silk fibers were used to 
fabricate a knitted scaffold in hope that it may provide sufficient strength as a 
replacement of injured ligament. 
Knitted silk scaffold was made out of one yarn of silk fibers by the knitting 
machine (Fig 2.1). After removal of sericin, silk fibroins in one fiber get loosed, 
making them very easy to fray out during the knitting process. Thus, it is more 
convenient to use raw silk fibers to fabricate the scaffold. The knitted scaffold was 
processed to remove sericin. The knotting sites of the scaffold are the most 
difficult places to have sericin thoroughly removed due to limited contact to 
NaCO3 aqueous solution. It is necessary that the processing system was agitated 
sufficiently. SEM images showed sericin was completely removed even at the 
knotting sites of the scaffold. The knitted scaffold possesses much larger pores 
than eukaryotic cells, which makes it difficult for direct cell loading. Coating the 
scaffold with 3-D porous structure will result in a novel scaffold having suitable 
pore size for cell attachment and proliferation. One of silk’s advantages as 
biomaterial is the convenience to tailor it into various forms of matrices [71,99]. 
Though insoluble in most solvents, including water, dilute acid and alkali, silk 
fibroin proteins can be dissolved in a mixture of salt and organic solvent at fixed 
ratios and an aqueous silk solution is obtained after dialysis against distilled water. 
By immersing the knitted scaffold into a certain volume of silk aqueous solution 
and freeze-drying, a layer of porous silk sponge was firmly coated on the knitted 
scaffold (Fig 3.). Since solubilization of silk fibroin proteins disrupted the 
secondary structure which contains a large amount of crystalline domains, the silk 
sponge made of silk fibroin solutions was not stable in water. Therefore, it was 
treated with 100% ethanol to induce β-sheet conformation transition in the fibroin, 
in order to generate water-stable silk structures. 
The thickness and pore size of the 3-D silk scaffold were controlled by the 
concentration and volume of silk fibroin solution. In this study, several volumes 
and concentrations were tested and 10ml of 1% silk solution was selected to make 
the scaffold. This protocol resulted in a 3-D scaffold with an average thickness of 
0.538 ± 0.104 mm and a pore size of around 50µm. However, the pores were not 
evenly distributed and the pore size varied from part to part. This was due to the 
freeze-drying process. On one hand, the process provides highly porous scaffold 
and is convenient to use; on the other hand, it has limited reproducibility and 
control of scaffold’s micro-architecture in terms of pore geometry, size and 
distribution, etc. Thus, the scaffold properties largely depend on the process itself 
rather than the design. Other methods such as gas forming and salt leaching are 
also being used to generate porous three-dimensional matrices in tissue 
engineering field [109-122]. Kim et al. fabricated a porous scaffold from silk 
solution  using  a salt  leaching  method  [97].  In  this  study,  NaCl  with different 
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particle sizes were added into silk fibroin solutions with different concentrations 
and the salt was extracted later by water. The resulted 3-D scaffold had a 
controllable porosity and pore size. The issue needed to consider here is the 
possibility of incorporating a knitted scaffold into the porous structure to make it 
strong enough for ACL reconstruction. Above all, this study provided an 
alternative choice to make porous scaffold with desired pore geometry. 
The water binding ability plays an important role on the behaviors of a 
biomaterial in terms of mechanical properties and mass transportation of nutrients 
and other components necessary for cell growth. This is usually assessed as the 
swelling ratio of a material. After processing, the surface of silk fibers was altered 
from hydrophilic sericin to hydrophobic silk fibroin, theoretically reducing the 
swelling ratio of knitted silk scaffold. Meanwhile, coating of porous silk sponge 
structure dramatically increased the porosity of the scaffold. Though porosity does 
not necessarily correlate with swelling ratio, it increased the contact area of silk 
fibroin with water. The scaffold exhibited a high swelling ratio of 571.90% ± 
142.98%. It was over 4 times and 3 times higher than that of sericin-free silk 
fibers and collagen scaffold, respectively [113, 114]. The high swelling ratio could 
be attributed to the porous silk structure coated on the scaffold. 
Mechanical properties of a biomaterial matrix are crucial for the success of 
ACL replacement. The maximal tensile load of human ACL is 1730 N. However, 
during daily activities, human ACL is merely exposed to tensile forces ranging 
from 3.87% (when ascending stairs) to 36.42% (when jogging) of the maximal 
tensile load [115]. What’s more, patients who are recovering from ACL 
implantation surgery are not supposed to perform intense physical activities. 
Therefore, it would be reasonable and safe if tissue-engineered ligament possessed 
40%-50% of maximal tensile load of normal ACL [106]. The maximal tensile 
load of rabbit is 150 ~ 200 N, thus a satisfactory tensile strength for the scaffold 
ranges from 60 ~ 100 N [106]. For the linear stiffness, it would be better for the 
scaffold to possess a relatively lower value than that of the native ACL, for it 
could transfer a load-bearing burden to developing tissues and promote functional 
regeneration [116]. The maximal tensile load of 3-D scaffold was lower than the 
knitted silk scaffold without coating. Freeze-drying process was proven not to 
have any adverse influence on the scaffold’s mechanical properties. Therefore, it 
may be due to the long time immersion in aqueous silk solution. The strong 
environmental stability of silk fibers is partially due to the extensive hydrogen 
bonding. When immersed in water, the hydrogen bonds were weakened, leading 
to a decrease in the mechanical properties of silk fibers [117]. Both the 3-D 
scaffold and knitted scaffold possessed a lower maximal tensile load than the 
satisfactory range. This can be increased by adding the numbers of silk fibers. 
However, since the 3-D scaffold needs to be rolled up to pass the 2-mm bone 
tunnel of rabbit in the in vivo study, the dimension of the scaffold must be limited. 
Adding silk fiber numbers will result in a larger diameter of the rolled scaffold, 
while the diameter of bone tunnel can not be increased any more, for that may 
cause rupture of the femur and tibia. The stiffness of 3-D scaffold was much lower 
than that of normal ACL. This is because as the scaffold was mounted on 
mechanical test machine, the porous structure was kept intact so the knitted 
scaffold was not fully pre-tensioned. Besides the evaluation of tensile strength and 
linear stiffness, future work should also be focused on the fatigue analysis of the 
scaffold in order to better understand its mechanical long – term behavior under 
cyclic tensile load.  
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4.2 In vitro tests 
When knitted scaffolds are used in tissue engineering applications, a gel 
system such as fibrin glue is usually required for cell seeding [102, 103, 105, 106, 
108]. These are often associated with problems of instability of the gel system and 
poor diffusion of nutrients and metabolic waste through the gel. What’s more, 
using gel system is both time and labor consuming. The novel 3-D silk scaffold 
developed in the presented study made it possible to directly load cells on the 
scaffold by simply pipetting a cell suspension onto them. Therefore, a method of 
loading cells in fibrin glue on knitted silk scaffold was used as the control group 
to study the function of the cell seeded novel 3-D scaffold in vitro. 
BMSCs are used more and more as the cell source in recent published 
studies regarding tissue engineering, especially tendon and ligament 
reconstructions. BMSCs are known to have the ability of self-renewal and 
differentiation into various mesenchymal cell lineages. Several studies 
demonstrated that BMSCs possessed superior properties of attachment, 
proliferation and synthesis of ECM rich in collagen type I when compared with 
ligament fibroblasts [44, 104]. In addition, BMSCs are easier to collect by needle 
aspiration and selected from other cells. All these advantages make them suitable 
candidate for ACL tissue engineering. However, although they can be isolated 
from other cells in bone marrow by their tendency to adhere to tissue culture 
plastic, there are still suspicions about the homogeneity of the cell populations 
obtained. A number of attempts have been made to establish a reliable protocol for 
BMSC culture, but none of them is widely accepted [118, 119]. In this study, we 
chose a protocol which is convenient to use and widely accepted in tissue 
engineering  research  for  BMSCs  culture  [120].  After  the primary cell colonies 
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were obtained, the frequency of subcultures of BMSCs must be limited to 
maintain a good proliferation rate and morphology. The proliferation of P3 cells 
(30days) stagnated and cell morphology changed obviously. In order to ensure the 
quality of tissue engineered constructs, it is better to use BMSCs of passage 2 or 
even younger ones.  
Measurement of cell viability and proliferation is the basis for numerous in 
vitro assays of cellular response to external factors. The yellow tetrazolium MTT, 
a member of tetrazolium salts, is a widely used and reliable reagent to test cell 
viability. MTT is reduced by metabolically active cells and partially reduced by 
the action of dehydrogenase enzymes. The resulting intracellular purple formazan 
can be solubilized by DMSO and quantified by spectrophotometric methods. MTT 
assay measures cell proliferation rate and cell viability. Cell numbers will affect 
MTT absorbance values, while the condition of cell metabolism is a more 
important factor. The cell loading efficiency was higher in the fibrin glue group, 
with less cells floating in cell culture medium 1 day after cell seeding. However, 
the MTT absorbance value of fibrin glue group measured at day 2 after cell 
seeding was lower (significant difference, p<0.5), indicating that the cells seeded 
on the 3-D scaffold proliferated faster and cell viability was better. This may be 
due to the limitation of transportation and diffusion of nutrients and metabolic 
waste through the fibrin glue. At day 14, cell proliferation in fibrin glue increased 
while cell seeded on the 3-D scaffold seemed stop growing. For the fibrin glue 
group, degradation of fibrin glue during the 2 weeks largely improved the 
environment of mass transportation, leading to an increasing proliferation rate. For 
the 3-D scaffold, two aspects might have contributed to the decline in cell 
proliferation. Firstly, there may still be limitations in mass transfer in the static 
cultivation, though better than that of fibrin glue at the beginning. Secondly, the 
starting cell number might have been too high and there is not enough space on 
the scaffold for cells to attach, thus some of the cells died during the 14 days. 
Scanning electron microscopy (SEM) is a direct way to observe cell 
proliferation conditions. It can also reveal the distribution of cells on the scaffold. 
Since SEM can only show the surface morphology of specimens, fibrin glue 
control group was not used in this experiment. When cells are seeded on matrices 
in vitro, it is a crucial step that the cells appropriately infiltrate into the matrices to 
generate a functional ACL replacement. The scaffold was coated with a layer of 
porous structure. As such, the cells were expected to penetrate and grow into the 
pores of the structure if properly stimulated. This is supported by a study in which 
fibroblasts infiltrated silk fibers to encapsulate individual fibroin filaments when 
stimulated as a part of a granulosous response to silk suture [86, 121]. From the 
SEM photographs, cells were found readily attached to surface of the scaffold and 
formed cell sheet during 1 week’s time. Most of the cells attached and proliferated 
on the area of porous structure. However, no obvious cell infiltration was 
observed even 2 weeks later. By existing cell seeding strategies, cells initially 
attach on the surface of the scaffold but no factors (e.g. perfusion) can effectively 
induce cell in-growth into the pores of scaffold. When cells continued to spread 
across the surface, the cell sheet formed walled off the interior space of the 
scaffold to proliferating cells and accumulating ECM [99].  
Cell proliferation can be influenced by various external factors such as the 
surface geometry of substrate, biomaterial composition and the presence of 
relevant   proteins   [122-125].   When  seeded  on  films  made  of   biodegradable 
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polymers including PCL, PLA, PLGA and co-polymers of them, both BMSCs and 
ACL fibroblasts had different responses in terms of cell adhesion, proliferation 
and morphology. Fibronectin (Fn) is a ligand for integrin-mediated cell adhesion 
to extracellular matrix. Biomaterials modified with Fn possess a more biomimetic 
surface, which may stimulate the reparative potential of cells [51]. It has been 
demonstrated that Fn is an important component during the healing of ACL 
injuries and early tendon repairs [126, 127]. Meanwhile, surface charge and 
chemistry of the underlying polymer substrate can lead to a change of Fn 
conformation, which in turns modulate integrin binding and control switching 
between proliferation and differentiation [128]. RGD is another integrin 
recognition sequence widely used to modify biomaterials [129]. Sofia et al. 
showed that silk films coated with RGD sequence potentially stimulated 
osteoblast adhesion and proliferation, as well as bone formation [130]. These all 
provide a promising way to enhance cell proliferation on the silk scaffold. The 
interaction of these factors with silk scaffold and their roles in ACL repair and 
regeneration need to be explored more, in order to better incorporate them into the 
design of scaffold.  
Compared with fibrin glue, silk scaffold provides cells with an 
environment more similar to the natural three-dimensional microstructure of ECM 
due to its porous 3-D structure. Therefore, it can better support cell elongation and 
synthesis of ECM. Observed by confocal microscopy, BMSCs were able to obtain 
a fibroblast-like, spindle-shaped morphology during one week’s time on the 
porous structure of the scaffold, while most of the cells in fibrin glue acquired 
irregular morphology. GAGs (glycosaminoglycans) are mainly found on the 
surface  of  cells  or  in  the  extracellular  matrix.  The  amount  of  soluble  GAGs 
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produced by cells into cell culture medium can reflect the cells’ capability of 
elaborating ECM. Cells seeded on the 3-D silk scaffold synthesized 16.74 ± 
3.04µg of soluble GAGs during two days time, 5 times more than that in fibrin 
glue. This value is also much higher than the result from a similar study [131]. 
However, the conclusion can not be drawn that this scaffold is superior over that 
one in terms of supporting soluble GAGs production until further normalization of 
the values with cell numbers is made. 
The 3-D silk scaffold also supported baseline levels expression of ACL 
related markers including collagen type I, collagen type III and tenascin-C. The 
values were normalized house-keeping gene – GAPDH. The expressions of all the 
three markers were much higher on silk scaffold than in the fibrin glue, indicating 
that the silk scaffold has greater potential of inducing BMSCs to differentiate into 
ACL fibroblasts. Future work should be done to test whether the scaffold also up-
regulate the expression of non-specific markers such as collagen type II. 
 The in vitro studies presented above demonstrated that the novel 3-D silk 
scaffold is a potential candidate for ACL tissue engineering. It consists of a 
knitted silk skeleton which provides the necessary mechanical strength and a 
porous microstructure which provide a suitable environment for cell attachment, 
proliferation and differentiation. Though there are still limitations in the design of 
this scaffold, it offers a valuable choice for ligament repair and thus in vivo test 
was made to further evaluate its function. 
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4.3 In vivo studies 
In vitro cellular assays and mechanical tests provide key information to 
help focus efforts on tissue engineering research. However, experimental testing 
in an appropriate animal model continues to be an essential step in the 
development of new tissue engineered constructs [132]. Therefore, it is necessary 
to test the function of the novel silk scaffold in vivo. Since cell seeding has been 
proved to improve the functionality of tissue engineered constructs, the scaffold 
was seeded with rabbit bone marrow stem cells in vitro and the construct was 
implanted in an animal model to replace its normal ACL [106, 133, 134]. 
Implantation of the scaffold only served as the control group. In this study, New 
Zealand White rabbits were chosen as the animal model based on several previous 
studies of tendon and ligament repair [56, 102, 103, 105, 106, 108]. In a previous 
study, seeded cells were detected 8 weeks after implantation, but only present in 
less than 10% of total area examined [101]. An earlier time point is required to 
evaluate the contribution of seeded cells to neo tissue growth, if there is any. 
Hence the time point of harvesting samples was 4 weeks after implantation.  
Histology analysis revealed fibroblast in-growth into the construct in both 
cross-sectional and longitudinal view of the constructs. Though the tissue in-
growth is less when compared with results from 20 weeks study [106], the results 
are still acceptable considering the short implantation period and better results are 
expected in samples from longer implantation time. In the outer part of the 
constructs, a thick layer of extracellular matrix and paralleled fibroblasts was 
found wrapped the scaffold. In contrast, the control group which was not seeded 
with donor cells showed very few cells adhering to silk fibers, and no extracellular 
matrix in the constructs.  It can be postulated  that the donor cells not only directly 
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contributed to tissue in-growth and extracellular matrix formation, but were able 
to help recruit progenitor/reparative cells by interacting with host cells to produce 
more extracellular matrix. Till now, no studies have reported to find fully mature 
collagen bundles in tissue engineered ACL prosthesis. However, several research 
groups reported relatively mature ACL regeneration, such as formation of 
collagen fibers, orientations and crimps [134, 135]. Short implantation period 
impedes further maturation of cell in-growth and elaboration of extracellular 
matrix. The limitations of the scaffold to encourage neo tissue development might 
be another reason for immature ACL replacements. 
Collagen plays an important role in the structural integrity and mechanical 
strength of ligaments, as well as the regeneration process. Paralleled collagen 
bundles provide high tensile strength for ligament to withstand physiological loads 
during daily lives. Collagen type I and collagen type III account for more than 
80% of the dry weight of a normal ligament [106]. Therefore, it is essential to 
know the content, orientation and maturation of collagen in tissue engineered 
ACL. In addition, the ratio of collagen types is of equal importance to collagen 
content. It has been reported that the ultimate fibril diameter obtained during 
fibrillogenesis appears to depend on the quantitative ratio in which the type I and 
type III collagens are secreted during fibril polymerization. Collagen type, 
distribution and quality vary considerably with age, location, ligament type and 
pathology [136-138]. In normal ACL, collagen type I content is 8~9 times more 
than that of collagen type III, and other collagens such as collagen V, VI and XII 
are present in small amount [99]. During the healing of an injured ligament or 
remodeling of immature construct, the ratio of collagen III and IV to collagen I 
will increase [139]. Photographs of immunohistochemistry of normal ACL 
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showed that collagen type I was much richer in extracellular matrix than collagen 
III and tenascin-C, another ACL specific molecule. The same trend was observed 
in tissue engineered constructs. Collagens were not only present in the outer layer 
of extracellular matrix, but penetrated into the scaffold, showing that the silk 
scaffold favored neo tissue development into ACL in an environment where 
various hints of ACL regeneration are present. The limitation of this study is that 
it can not quantitatively evaluate the collagen content or the relative ratios of 
different types. To achieve this, collagen content can be extracted from the 
samples and experimental methods such as western blot analysis can be used in 
future studies. Other considerations like collagen cross-linking, fiber size and 
homogeneity can also be measured. 
The primary function of ligaments is to transmit force; hence the 
mechanical properties of the constructs are usually a crucial factor for judging the 
effect of a treatment. The silk scaffold has already been tested of its mechanical 
properties in vitro. Since silk fibers take as long as more than one year to fully 
degrade in vivo and tissue in-growth of the construct is not mature enough to form 
a functional ligament during 4 weeks time, we did not expect the mechanical tests 
would provide much information about tissue development. Thereby, two samples 
from each group were used in mechanical tests to give a glimpse at the structural 
conditions of the constructs. One of the samples from control group almost 
ruptured upon harvest from the knee joint. The other sample exhibited a maximal 
tensile load of 23.82% of normal ACL, which is higher than that of previous 
published study. Both samples from the experimental group exhibited lower 
maximal tensile load than in vitro tests, but similar to that of published study 
[106]. Stiffness of all the three samples was much lower than that of normal ACL. 
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Since the sample size was not big enough and no statistical analysis was made, no 
certain conclusion can be drawn from the data. However, it seems necessary to 
further improve the mechanical strength of the current scaffold for future tests. 
The design of the scaffold can also be adjusted to match the stiffness of normal 
ligament. The strength of the fixation site at drilled bone tunnel is another 
important issue to be considered in ACL reconstruction. Normal ACL bony 
insertion zone has properties intermediate between ligament and bone. During 
mechanical tests, all the four normal ACLs ruptured at bony attachment site, 
indicating it the weakest part of the ligament. The interface between a synthetic 
material and a living tissue is usually a region of high stress. A reliable fixation of 
the construct to femur and tibia will contribute a lot to the success of the treatment. 
In this study, the two ends of silk scaffold were sutured and the suture was tied to 
a screw fixed in the bone. During mechanical tests, all the three constructs 
ruptured in the middle part, suggesting that the fixation method is effective. On 












Conclusion and Future work 
 
5.1 Conclusion 
The aim of this project was to develop a biocompatible three dimensional 
scaffold using silk fibroin as the biomaterial for ACL regeneration. Given this 
objective, knowledge relevant to the topic was reviewed and classified. The 
importance and requirements of a suitable biomaterial scaffold for a functional 
ACL prosthesis were fully understood and several achievements regarding the 
design and test of a novel silk scaffold have been made. 
The novel silk scaffold consists of a skeleton of knitted silk scaffold and a 
coated layer of porous silk sponge. Fabrication procedures including knitting, 
sericin removal and freeze-drying were optimized. The resulted scaffold was three 
dimensional with a pore size of around 50µm. Characterizations of the scaffold 
such as surface morphology, swelling properties and mechanical properties were 
studied. Bone marrow stem cells were selected as the cell source for ACL 
regeneration. In vitro tests compared the scaffold and conventional fibrin glue as 
substrate for cell attachment, proliferation and differentiation. The cells readily 
attached to the scaffold, proliferated and formed cell sheet to fill gaps of the 
porous structure one week after cell seeding. Cell viability was higher on the 
scaffold than in fibrin glue initially, but cells seemed grow faster in fibrin glue. 
Cells obtained a fibroblast-like, spindle-shaped morphology on the scaffold in one 
week, while cells in fibrin glue failed to exhibit such morphology even two weeks 
later.  The  silk  scaffold  up-regulated  the  expression  of  ACL  specific  markers 
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including collagen type I, type III and tenascin-C, when normalized with gene 
expressions before cell seeding. Again, expression levels of these genes were 
much lower in fibrin glue. The silk scaffold was also shown to support synthesis 
of ECM components – soluble GAGs more than fibrin glue did. Therefore, it 
could be concluded that the three dimensional silk scaffold is a potent candidate 
for tissue engineered ACL replacement. 
Findings from in vivo studies on a rabbit model supplemented the 
conclusion drawn from in vitro tests. 4 weeks after implantation, fibroblast in-
growth and extracellular matrix wrap were observed in constructs seeded with 
donor cells. In contrast, implantation of the scaffold only failed to show tissue in-
growth or extracellular matrix formation. Contents of collagen I, III and tenascin-
C in cell-seeded constructs exhibited the same trend as observed in normal ACL. 
These confirmed the conclusion that the novel silk scaffold favors development of 
neo tissue for ACL repair. Due to tight schedule and limited sample size, only 3 
samples were used in mechanical tests. The results suggested necessity to improve 










5.2 Recommendations for future work 
Using knitted scaffold as the skeleton and porous structure for cell 
attachment is a reasonable design for ligament tissue engineering which requires 
sufficient mechanical properties and capability to support tissue growth. The 
scaffold made in this project was designed under such principles, but its 
mechanical strength seemed not sufficient to replace a normal ACL. More work 
needs to be done to make its mechanical properties match those of normal ACL 
better. One way is to try to strengthen the material itself. Silk fibroin is a versatile 
biomaterial and proper modifications of this material may strengthen its physical 
structure. Coating of 5% gelatin and cross-linking with NDGA increased the 
maximum tensile stress of single silk fiber by 43% [140]. Study on the physical 
and chemical properties of silk fibroin may lead to more findings of ways to 
increase its mechanical strength. Another factor which influences the mechanical 
properties is the design and fabrication process of the scaffold. To get a scaffold 
with desired physical properties, theoretical methods like mathematic and 
computational modeling can be incorporated more in the scaffold design. Altman 
et al [99] developed a wire-rope silk matrix with desired mechanical properties, 
which were precisely predicted by Costello’s equation. Other methods to produce 
porous scaffold should be attempted to get evenly distributed pores and predicted 
porosity and pore size. Silk fibers were weakened when boiled in NaCO3 aqueous 
solution and immersed in water. A better fabrication protocol should try to avoid 
such steps so that the mechanical strength of the material would not be impaired.  
   The silk scaffold was proven to support BMSCs proliferation and 
differentiation. However, there is still room to improve its biocompatibility. 
Coating   the  scaffold  surface  with  cell  adhesion   related   molecules   such  as 
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fibronectin and RGD sequence is proven to enhance cell adhesion efficiency of 
biomaterial scaffold. Genetic methods which tailor silk fibroin proteins at gene 
level provide another choice to alter the surface properties of the material. Some 
regulatory factors can be incorporated into the process of tissue formation on the 
scaffold. A number of growth factors such as TGF-β, IGF-II and bFGF are proven 
to increase cell proliferation. Moreover, insulin, TGF- β and IGF-II are able to 
promote protein expression and ECM generation in soft connective tissues. These 
regulatory factors can be supplemented in culture medium, or encapsulated in the 
scaffold itself. Mechanical signals can also affect the growth and development of 
tissue engineered ligament. When applied with physiologically relevant cyclic 
strain, human BMSCs can be induced to differentiate into ligament-like cells 
without specific ligament growth and regulatory factors. One way to apply 
specific mechanical stimulations on tissue engineered ligament is to culture it in a 
bioreactor system. Some bioreactor systems are commercially available today. 
However, no one is especially tailored for ligament tissues. A bioreactor system 
specifically designed to develop tissue engineered ligament in vitro is being 
optimized and tested in our lab. We expect that this bioreactor system can be 
utilized in the combination of the silk scaffold to develop a functional ACL 
prosthesis in the near future. 
There are also some improvements to make in the analytical methods of 
the project. When performing RT-PCR, not only the ACL specific markers should 
be tested, but the genes related with other tissues like bone and cartilage should be 
monitored to ensure the right direction of differentiation of the cells. In the in vivo 
animal study,  a longer implantation time and larger sample size should be 
adopted.  Besides  immunohistochemical  staining  of   ACL  extracellular  matrix 
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proteins, quantitative analysis should also be performed to accurately determine 
the condition of neo tissue development. Donor cells can be labeled with 
fluorescent dye to trace their survival in the neo tissue after a long time of 
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